Jason M. Broderick

Articles

FDA updates label for mitomycin gel in UTUC

September 29, 2022

The FDA has updated the label for mitomycin-containing reverse thermal gel (Jelmyto) in low-grade upper-tract urothelial cancer by extending the in-use period for pyelocalyceal solution admixture.